Anju Nohria, MD
Enriched profileDirector of the Cardio-Oncology Program, NYU Langone Hospitals - Manhattan; Faculty Member, Department of Medicine, NYU Grossman School of Medicine · NYU Langone Health
Anju Nohria is Director of the Cardio-Oncology Program, NYU Langone Hospitals - Manhattan; Faculty Member, Department of Medicine, NYU Grossman School of Medicine at NYU Langone Health. OpenAlex indexes 331 publications with 14,939 citations (h-index 62); ClinicalTrials.gov lists 4 registered studies with this person as an investigator.
Data verified 9 Oct 2026
Overview
Updated 14 Oct 2026
Anju Nohria, MD, is Director of the Cardio-Oncology Program, NYU Langone Hospitals - Manhattan at NYU Langone Health. The public record shows 331 publications with 14,939 citations (h-index 62), centered on Chemotherapy-induced cardiotoxicity and mitigation, Heart Failure Treatment and Management, Cardiac tumors and thrombi. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 6 companies.
- Most recent indexed publication: 2026 · Circulation
- Top research focus: Chemotherapy-induced cardiotoxicity and mitigation
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 15 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 142.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy.
Sponsor: Dana-Farber Cancer Institute
- Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy
Sponsor: Abbott Medical Devices
- Rho Kinase (ROCK) Inhibition in Carotid Atherosclerosis
Sponsor: Brigham and Women's Hospital
Industry payments
Updated 14 Oct 2026
6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca UK LimitedProgram year20258 payments$20,280openpaymentsdata.cms.gov ↗
- Sumitomo Pharma America, Inc.Program year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
79.9%Statin20.8%Atorvastatin Calcium54%Rosuvastatin Calcium31%Pravastatin Sodium12%Simvastatin3%Part D≥197 patientsBeta blocker18.8%Metoprolol Succinate53%Carvedilol26%Bisoprolol Fumarate9%Atenolol4%Labetalol Hcl4%Sotalol2%Metoprolol Tartrate2%Part D<11 patients+ 18 more classes in this area
Metabolism & gastrointestinal
8.4%SGLT2 inhibitor4.3%Jardiance91%Farxiga10%Part D<11 patientsPotassium supplement1.7%Potassium Chloride88%Klor-Con M2012%Part D<11 patients+ 5 more classes in this area
Blood & clotting
7.9%Factor Xa inhibitor7.1%Eliquis87%Xarelto13%Part D≥100 patientsP2Y12 inhibitor0.7%Clopidogrel100%Part D≥13 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 14 Oct 2026
18 congress contributions (2010–2026) across AACR, ASCO, ASH, ASTRO per OpenAlex. The most recent:
- CV CARE: Cardiovascular care of androgen-related effects in prostate cancer patients.
ASCO Annual Meeting
ASCO2026Co-author - Survival of elderly patients with HER2+/HR- metastatic breast cancer in clinical practice: SEER-Medicare data 2012-2016.
ASCO Annual Meeting
ASCO2022Co-author - Genetic Predictors of Anthracycline Mediated Cardiomyopathy with Induction Chemotherapy in Acute Myeloid Leukemia (AML)
ASH Annual Meeting
ASH2022Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Association of Environmental Injustice and Cardiovascular Diseases and Risk Factors in the United States.
Journal of the American Heart Association
Article2024 - Associations Between Preimplant Cancer Type and Left Ventricular Assist Device Outcomes: An INTERMACS Registry Analysis.
ASAIO journal (American Society for Artificial Internal Organs
Article2024 - Reducing radiation to the heart in breast cancer: is that all that matters?
European heart journal
Comment2023
Most-cited works
by citation count (OpenAlex)- 01Myocarditis in Patients Treated With Immune Checkpoint InhibitorsArticle1,588 citations2018
- 02
- 03
- 04Cardiorenal InteractionsArticle593 citations2008
- 05Medical Management of Advanced Heart FailureArticle467 citations2002
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Board certified
American Board of Internal Medicine: Advanced Heart Failure and Transplant Cardiology
2014verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
Secondary affiliations
appointments beyond the home institution- Perlmutter Cancer Center
NYU Langone (34th Street office)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →nyulangone.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Gareth Morgan, MD
NYU Langone Health
Nathan Levin, MD
NYU Langone Health
Ira Jacobson, MD
NYU Langone Health
Michael Zelefsky, MD
NYU Langone Health
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)